Mark Chang Hwa Liu

Associate Professor

1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark Chang Hwa Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Asthma Medicine & Life Sciences
Lung Medicine & Life Sciences
Allergens Medicine & Life Sciences
Bronchoalveolar Lavage Fluid Medicine & Life Sciences
Bronchoalveolar Lavage Medicine & Life Sciences
Eosinophils Medicine & Life Sciences
Basophils Medicine & Life Sciences
Inflammation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility

Humbert, M., Albers, F. C., Bratton, D. J., Yancey, S. W., Liu, M. C. H., Hozawa, S., Llanos, J. P. & Kwon, N., Jul 1 2019, In : Respiratory Medicine. 154, p. 69-75 7 p.

Research output: Contribution to journalArticle

Asthma
Placebos
Forced Expiratory Volume
Biological Therapy
Standard of Care

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Chapman, K. R., Albers, F. C., Chipps, B., Muñoz, X., Devouassoux, G., Bergna, M., Galkin, D., Azmi, J., Mouneimne, D., Price, R. G. & Liu, M. C., Sep 1 2019, In : Allergy: European Journal of Allergy and Clinical Immunology. 74, 9, p. 1716-1726 11 p.

Research output: Contribution to journalArticle

Open Access
Asthma
Omalizumab
mepolizumab
Surveys and Questionnaires
Biological Products

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use

Albers, F. C., Hozawa, S., Bratton, D. J., Yancey, S. W., Prazma, C. M., Humbert, M. & Liu, M. C., Jan 1 2019, (Accepted/In press) In : Allergy: European Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalLetter

Open Access
Biological Products
Eosinophils
Asthma
Therapeutics
Omalizumab

Enhanced antigen presenting and T cell functions during late-phase allergic responses in the lung

Liu, M. C. H., Xiao, H., Breslin, L. M., Bochner, B. S. & Schroeder, J. T., Mar 1 2018, In : Clinical and Experimental Allergy. 48, 3, p. 334-342 9 p.

Research output: Contribution to journalArticle

Antigen-Presenting Cells
Allergens
Neuropilin-1
Bronchoalveolar Lavage
T-Lymphocytes

Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease

Pothoven, K. L., Norton, J. E., Suh, L. A., Carter, R. G., Harris, K. E., Biyasheva, A., Welch, K., Shintani-Smith, S., Conley, D. B., Liu, M. C. H., Kato, A., Avila, P. C., Hamid, Q., Grammer, L. C., Peters, A. T., Kern, R. C., Tan, B. K. & Schleimer, R. P., Jun 27 2016, (Accepted/In press) In : Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalArticle

Oncostatin M
Neutrophils
Cytokines
Nasal Polyps
Granulocyte-Macrophage Colony-Stimulating Factor